Diligence Firm vs Growth Execution Firm: Who Does What in a PE Deal (2026)
One firm decides whether the deal model holds. The other makes it true. What commercial diligence firms and growth execution firms each do, why 2026 blurred the line, and whether one firm should ever do both.
A commercial diligence firm validates a deal thesis before close — market sizing, voice of customer, competitive dynamics, win/loss. A growth execution firm delivers the value-creation plan after close — embedded operators building the data foundation, commercial engine, and go-to-market capability the thesis assumed. One decides whether the model holds; the other makes it true.
The map, in one line: diligence firms answer "should we buy it," execution firms answer "now what," and 2026 is the year sponsors started demanding both answers before wiring the money.
What a commercial diligence firm actually does
A commercial diligence firm is hired by the deal team, pre-close, to stress-test the commercial half of the investment thesis. The classic scope is a four-to-six-week sprint: market sizing and TAM work, voice-of-customer interviews, win/loss analysis, competitive landscape, pricing dynamics, and a view on whether the revenue plan in the model survives contact with actual customers.
The archetype is L.E.K. and the boutique CDD shops that compete with it, plus data-led specialists that focus on the digital and channel side of the same question. The deliverable is a report: investment-committee-ready, red flags surfaced, thesis validated, qualified, or killed. The firm is paid by the fund, its client is the deal team, and its job ends at close. Quality-of-earnings work runs alongside on the financial side; commercial diligence is the same idea applied to the market instead of the ledger.
The failure mode of the category is well understood: a thesis that was wrong. If the market is smaller than the CIM claimed, the customers are less loyal than the retention curve implied, or the competitive moat is a drainage ditch, the diligence firm exists to find that out while the sponsor can still walk away.
What a growth execution firm actually does
A growth execution firm starts where the diligence report stops. It is engaged post-close, usually by the sponsor and the portfolio-company CEO together, to deliver the value-creation plan the deal was underwritten on: build the data foundation so revenue is actually measurable, rebuild the customer-acquisition engine, install reporting and accountability, and stay embedded until the capability exists inside the company rather than inside a slide.
The unit of engagement is months, not weeks. The team profile is operators rather than analysts: people who have run marketing, sales, and commercial functions, working inside the business alongside management. The deliverable is not a report; it is an installed system and the revenue clarity that comes with it. The category sits between the diligence report and the board meeting, and it is accountable to the plan in a way an advisor is not. For where the category sits against adjacent models, see growth equity vs growth execution and in-house portfolio operations vs external operating partner firms.
The failure mode is the mirror image of diligence: a plan that was right and never executed. The thesis holds, the levers exist, and eighteen months later nobody has pulled them because the company never had the team, the data, or the operating cadence to do it.
Why 2026 blurred the line
The two categories used to hand off cleanly at close. The 2026 mid-year outlooks broke the handoff. PwC's mid-year private equity outlook says "underwriting value creation during the diligence phase is rapidly becoming table stakes," and Bain, EY, and BDO published variations of the same sentence. Entry multiples and financing costs no longer carry the return, so the operational plan has to be proven plausible before close, not sketched after it.
That pulled both categories across the line. Diligence firms now bolt "value-creation roadmaps" onto CDD reports, so the sponsor gets a plan written by people who will never execute it. Execution firms get pulled into pre-close "growth diligence," pressure-testing whether the target can actually pull the levers the model assumes. EY frames diligence as vital to value creation; West Monroe calls pre-deal value-creation planning the missing link. The consensus is real, and it has an obvious consequence: the sponsor now has to decide which firm type owns which question, because both types are volunteering for both.
Diligence firm vs growth execution firm
| Commercial diligence firm | Growth execution firm | |
|---|---|---|
| When engaged | Pre-close, inside the deal timeline | Post-close, across the hold |
| Core question | Does the thesis hold? | Can the company deliver it? |
| Team profile | Analysts and researchers | Operators who have run the function |
| Duration | 4-6 week sprint | Months, embedded |
| Deliverable | Report and red flags | Installed capability and revenue clarity |
| Who hires | The deal team | Sponsor and portfolio CEO |
| Failure mode | Thesis was wrong | Plan never executed |
Should the same firm do both?
The case for one firm is continuity. The people who interviewed forty customers pre-close arrive at day one already knowing where the bodies are buried; nothing is lost in the handoff between report and plan.
The case against is that a firm grading its own diligence is marking its own homework. If the value-creation plan underperforms, was the thesis wrong or the execution weak? A firm that wrote both has an answer prepared, and it will not be either of those. Pre-close validation and post-close delivery are also different muscles: interviewing a market is not the same skill as rebuilding a commercial engine inside it, whatever the proposal deck says.
The pattern that is emerging in practice: a diligence firm validates, an execution firm builds, and both are at the table at close so the handoff is a conversation rather than a PDF. On the validation side that means an L.E.K.-type or boutique CDD shop. On the execution side, firms that embed operators in PE-backed companies include Craig Group, Growth Operators, and Claymore Partners. When the plan is distress rather than growth, the category changes again: that is Alvarez & Marsal and AlixPartners territory, covered in operating partner vs turnaround firm.
Which firm type for which moment
| Deal-stage need | Right firm type |
|---|---|
| Pre-LOI market check | Commercial diligence firm |
| Underwriting specific growth levers | CDD firm, with an execution firm reviewing feasibility |
| Day 1 to day 100 delivery | Growth execution firm |
| Portfolio-wide commercial capability | Growth execution firm |
| Company bleeding cash | Turnaround firm |
| Expert calls only | Expert network |
| Episodic project with defined scope | Marketplace, per BluWave alternatives |
One adjacent read before you hire anyone on the execution side: the questions to ask before hiring an operating partner apply almost verbatim to execution firms.
Frequently asked questions
What is the difference between a diligence firm and a growth execution firm?
A commercial diligence firm validates a deal thesis before close — market sizing, voice of customer, competitive dynamics, win/loss. A growth execution firm delivers the value-creation plan after close — embedded operators building the data foundation, commercial engine, and go-to-market capability the thesis assumed. One decides whether the model holds; the other makes it true.
What does a commercial diligence firm do in private equity?
Validates the commercial thesis pre-close: market sizing, customer interviews, competitive analysis, win/loss — typically a 4-6 week sprint ending in an investment-committee-ready report.
What is a growth execution firm?
A firm that embeds operators in PE-backed companies post-close to build the data, marketing, and commercial capabilities the deal thesis assumed — accountable for delivering the value-creation plan, not just recommending one.
Can the same firm do diligence and post-close execution?
Sometimes — continuity is real — but pre-close validation and post-close delivery are different muscles, and a firm grading its own diligence carries an obvious conflict. Many sponsors pair a CDD firm with a separate execution firm.
Why do PE firms now underwrite value creation during diligence?
Multiple 2026 mid-year outlooks (PwC, Bain, EY) report that entry multiples and financing costs no longer carry returns; operational value creation has to be proven plausible before the deal closes.
Who are examples of growth execution firms for PE portfolio companies?
Firms that embed operators post-close include Claymore Partners, Craig Group, and Growth Operators; turnaround specialists like Alvarez & Marsal serve distressed situations rather than growth mandates.
Related reading: Growth Equity vs Growth Execution · In-House vs External Operating Partner · BluWave Alternatives for PE Firms
